The global market for mRNA vaccines and therapeutics is expanding due to the rising incidence of chronic illnesses worldwide.
New York, USA, Dec. 26, 2024 (GLOBE NEWSWIRE) — Market Overview
The market for mRNA vaccines and therapeutics is poised to grow, according to the latest research study by Polaris Market Research. The mRNA vaccines and therapeutics market size was valued at USD 54.32 billion in 2024 and is projected to grow to USD 253.83 billion by 2034. It is anticipated to register a CAGR of 16.7% during 2025–2034.
Market Introduction
Messenger ribonucleic acid (mRNA) is a type of single-stranded RNA that acts as a basis for protein synthesis in the cells. mRNA and therapeutics combine the desirable immunological properties and work by introducing a mRNA strand corresponding to a single protein. Cells then use the mRNA to produce the viral protein. After this, the immune system responds to it by developing specific proteins called antibodies. Antibodies help the body fight infection by recognizing and binding to antigens, which are sugars or proteins found on the surface of pathogens or toxins. Once produced, the antibodies stay in the body even after the pathogen or virus has been destroyed.
Download Free Sample PDF Copy of Report:
Market Report Scope
| Report Attributes | Details |
| Market Size Value in 2024 | USD 54.32 billion |
| Market Size Value in 2025 | USD 63.28 billion |
| Revenue Forecast by 2034 | USD 253.83 billion |
| CAGR | 16.7% from 2025 to 2034 |
| Base Year | 2024 |
| Historical Data | 2020–2023 |
| Forecast Period | 2025–2034 |
Market Key Players
The leading market participants are focusing on R&D to expand their product offerings. Also, they are adopting several strategic initiatives to expand their global presence.
A few of the mRNA vaccines and therapeutics market key players are:
- Pfizer Inc.
- Moderna, Inc.
- BioNTech SE
- GlaxoSmithKline
- CureVac N.V.
- AstraZeneca
- Kernal Biologics
- Pantherna Therapeutics
- pHion Therapeutics
- Recode Therapeutics
- Strand Therapeutics
Market Drivers and Opportunities
Rising R&D Initiatives and Strategic Partnerships: The leading market participants and key companies are increasingly focusing on R&D and strategic partnerships to accelerate the development of new mRNA vaccines. They are pooling expertise, technologies, and talent to overcome manufacturing and scientific challenges. Thus, the growing focus on R&D and the adoption of strategic partnerships is fueling the mRNA vaccines and therapeutics market development.
Increased Regulatory Approvals: Regulatory approvals play a crucial role in building public confidence and encouraging broader applications of mRNA vaccines in healthcare. In addition, they pave the way for additional investments in mRNA vaccines and therapeutics, research, development, and production infrastructure, facilitating mass manufacturing of innovative products.
Growing Incidence of Infectious Diseases: The rising prevalence of infectious diseases worldwide has prompted market participants to develop vaccines that can adapt to various virus variants. This, in turn, has fueled the mRNA vaccines and therapeutics market demand across the globe.
Request For Discount on This Report Before Purchase:
Regional Overview
The research report offers market insights into all the key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America: North America dominated the mRNA vaccines and therapeutics market in 2024. The regional market dominance is primarily fueled by the presence of a robust healthcare infrastructure and significant investments in research and development. In addition, high awareness of medical technologies and a strong regulatory framework further contribute to the robust growth of the market in the region.
Asia Pacific: The Asia Pacific mRNA vaccines and therapeutics market is projected to register the fastest CAGR from 2025 to 2034. The increasing investments in biotechnology and the growing prevalence of infectious diseases are driving the demand for mRNA vaccines and therapeutics in Asia Pacific. Strategic partnerships and collaborations have further accelerated the innovation and production of mRNA vaccines in the region.
Inquire More About This Report Before Purchase:
Market Segmentation
By Type Outlook
- Self-Amplifying mRNA-based Vaccines
- Conventional Non-Amplifying mRNA-Based Vaccines
By Application Outlook
- Cancer
- Infectious Diseases
- Autoimmune Diseases
- Others
By Treatment Type Outlook
- Monoclonal Antibody
- Gene Therapy
- Cell Therapy
- Other
By End User Outlook
- Research Laboratories and Organizations
- Hospitals
- Clinics
- Others
By Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Browse Related Reports:
Blood Pressure Cuffs Market:
https://www.polarismarketresearch.com/industry-analysis/blood-pressure-cuffs-market
Hematology Analyzers and Reagents Market:
https://www.polarismarketresearch.com/industry-analysis/hematology-analyzers-and-reagents-market
Surgical Sponges Market:
https://www.polarismarketresearch.com/industry-analysis/surgical-sponges-market
Liposomal Doxorubicin Market:
https://www.polarismarketresearch.com/industry-analysis/liposomal-doxorubicin-market
Angina Pectoris Drugs Market:
https://www.polarismarketresearch.com/industry-analysis/angina-pectoris-drugs-market
Arthroscopy Market:
https://www.polarismarketresearch.com/industry-analysis/arthroscopy-market
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
- LGI Homes Expands Presence Near Buffalo with New Minneapolis-Area Community - May 9, 2025
- From Black Hawks to Boardrooms: Former Lockheed Engineer Now at Drew Sutton Leadership Rewires CEOs to Lead Without Burnout - May 9, 2025
- Montclair Pediatric Dentistry Sets a New Standard in Compassionate Pediatric Dental Care Across the Bay Area - May 9, 2025
